Zimmer Biomet
930 hedge funds and large institutions have $24.9B invested in Zimmer Biomet in 2020 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 265 increasing their positions, 367 reducing their positions, and 90 closing their positions.
45% more call options, than puts
Call options by funds: $68M | Put options by funds: $47M
40% more funds holding in top 10
Funds holding in top 10: 10 → 14 (+4)
12% more capital invested
Capital invested by funds: $22.2B → $24.9B (+$2.7B)
1.32% less ownership
Funds ownership: 92.55% → 91.23% (-1.3%)
2% less funds holding
Funds holding: 945 → 930 (-15)
11% less first-time investments, than exits
New positions opened: 80 | Existing positions closed: 90
28% less repeat investments, than reductions
Existing positions increased: 265 | Existing positions reduced: 367
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$227M |
| 2 |
BlackRock
New York
|
+$159M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$155M |
| 4 |
HM
HealthCor Management
New York
|
+$149M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$80.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nordea Investment Management
Stockholm,
Sweden
|
-$504M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$165M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$124M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$96.1M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$79.5M |
ZBH Hedge Fund Activity: Q3 2020 in Review
930 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2020, worth a combined $24.9B — up 12% from $22.2B a quarter earlier.
Sellers outnumbered buyers: 90 funds closed out of ZBH and 80 opened new positions — a net loss of 10 holders — while 367 trimmed existing stakes and 265 added.
The largest buyer was Viking Global Investors, opening a new position worth an estimated $227M. The largest seller was Nordea Investment Management, cutting an estimated $504M.
- 930 institutional investors held Zimmer Biomet (ZBH) as of Q3 2020, down from 945 in Q2 2020.
- Funds reported $24.9B of Zimmer Biomet stock for Q3 2020, up 12% quarter-over-quarter.
- 80 funds opened new Zimmer Biomet positions in Q3 2020 and 90 closed out, a net change of -10 holders.
- The largest Zimmer Biomet buyer in Q3 2020 was Viking Global Investors, an estimated $227M added.
- The largest Zimmer Biomet seller in Q3 2020 was Nordea Investment Management, an estimated $504M sold.
Based on aggregated 13F filings for Q3 2020.